Download PDF
Horm Metab Res 2011; 43(3): 209-215
DOI: 10.1055/s-0031-1271622
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Change in the Amount of Body Fat and IL-6 Levels is Related to Altered Insulin Sensitivity in Type 1 Diabetes Patients with or without Diabetic Nephropathy

M. K. Svensson1 , J. W. Eriksson1 , 2
  • 1Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
  • 2AstraZeneca, R & D, Mölndal, Sweden
Further Information

Publication History

received 05.07.2010

accepted 20.12.2010

Publication Date:
14 February 2011 (online)

Also available at
    Permissions and Reprints

Abstract

Insulin resistance (IR) is found early-on in renal disease. The aim of this study was to prospectively evaluate if a change in glomerular filtration rate (GFR) or in endocrine and inflammatory factors over time alters insulin sensitivity in patients with type 1 diabetes (T1D) or without diabetic nephropathy (DN) at baseline. 20 T1D with (DN+, n=12) or without DN (DN–, n=8) were re-examined after 5.0±0.4 years. GFR was determined by 51Cr-EDTA clearance. Insulin sensitivity was assessed by hyperinsulinemic (56 mU/m2/min), euglycemic clamp (M-value at steady state during clamp) and calculated per lean body mass. Body composition was determined by bioimpedance. No association was found between change in GFR and change in M-value over time. Instead, change in M-value was associated to change in fat mass (%) and change in IL-6 levels in all subjects taken together (r=−0.55, p=0.012 and r=−0.62, p=0.006). These association were verified in the multivariate regression analyses. Findings were similar in DN − and DN +, respectively, but the change in IL-6 was only significantly associated with altered M-value in DN+ subjects. This prospective study indicates that change in amount body fat and levels of inflammatory cytokines, such as IL-6, contribute to change in insulin resistance over time in type 1 diabetes patients with and without diabetic nephropathy.

Key words

type 1 diabetes - diabetic nephropathy - glucose metabolism - insulin sensitivity - hormones - cytokines

References

  • 1 Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.  Diabetes. 1983;  32 (S 02) 64-78
    Google Scholar
  • 2 Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.  Lancet. 1993;  342 883-887
    Google Scholar
  • 3 Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.  Lancet. 1988;  2 530-533
    Google Scholar
  • 4 Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study.  Diabetes. 1998;  47 793-800
    Google Scholar
  • 5 DeFronzo RA, Alvestrand A. Glucose intolerance in uremia: site and mechanism.  Am J Clin Nutr. 1980;  33 1438-1445
    Google Scholar
  • 6 DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia.  J Clin Invest. 1981;  67 563-568
    Google Scholar
  • 7 Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity.  Diabetologia. 1995;  38 565-572
    Google Scholar
  • 8 Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease.  Kidney Int. 1998;  53 1343-1347
    Google Scholar
  • 9 Svensson M, Yu ZW, Eriksson JW. A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy.  Eur J Clin Invest. 2002;  32 100-109
    Google Scholar
  • 10 Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.  J Am Soc Nephrol. 2005;  16 1091-1098
    Google Scholar
  • 11 Svensson M, Eriksson JW. Insulin resistance in diabetic nephropathy – cause or consequence?.  Diabetes Metab Res Rev. 2006;  22 401-410
    Google Scholar
  • 12 Cooper-DeHoff RM, Pacanowski MA, Pepine CJ. Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.  J Am Coll Cardiol. 2009;  53 S28-S34
    Google Scholar
  • 13 Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gomez-Campdera F, Vega A, Abad S, Luno J. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.  J Am Soc Nephrol. 2006;  17 S231-S235
    Google Scholar
  • 14 Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients.  Diabet Med. 2003;  20 642-645
    Google Scholar
  • 15 Svensson M, Eriksson JW. No direct link between albumin excretion rate and insulin resistance – a study in type 1 diabetes patients with mild nephropathy.  Horm Metab Res. 2002;  34 254-259
    Google Scholar
  • 16 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.  Diabetes Care. 1997;  20 1183-1197
    Google Scholar
  • 17 Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate.  Scand J Clin Lab Invest. 1981;  41 611-616
    Google Scholar
  • 18 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance.  Am J Physiol. 1979;  237 E214-E223
    Google Scholar
  • 19 DeFronzo RA, Ferrannini E, Sato Y, Felig P, Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake.  J Clin Invest. 1981;  68 1468-1474
    Google Scholar
  • 20 Bokemark L, Froden A, Attvall S, Wikstrand J, Fagerberg B. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility.  Scand J Clin Lab Invest. 2000;  60 27-36
    Google Scholar
  • 21 Eriksson JW, Jansson PA, Foley K, Lithell H. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.  J Hypertens. 1996;  14 1469-1475
    Google Scholar
  • 22 Ahmad J, Siddiqui MA, Ahmad H. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.  Diabetes Care. 1997;  20 1576-1581
    Google Scholar
  • 23 Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin P. Essential hypertension is associated with decreased insulin clearance and insulin resistance.  Hypertension. 1997;  29 111-114
    Google Scholar
  • 24 Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.  Am J Physiol. 1983;  244 E517-E527
    Google Scholar
  • 25 Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition.  J Appl Physiol. 1986;  60 1327-1332
    Google Scholar
  • 26 Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance in adult polycystic kidney disease.  Kidney Int. 1997;  52 503-508
    Google Scholar
  • 27 Nerpin E, Riserus U, Ingelsson E, Sundstrom J, Jobs M, Larsson A, Basu S, Arnlov J. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort.  Diabetes Care. 2008;  31 1550-1555
    Google Scholar
  • 28 Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease.  Cochrane Database Syst Rev. 2007;  CD002181
    Google Scholar
  • 29 Trirogoff ML, Shintani A, Himmelfarb J, Ikizler TA. Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3–4 chronic kidney disease patients.  Am J Clin Nutr. 2007;  86 1642-1648
    Google Scholar
  • 30 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.  J Clin Invest. 1995;  95 2409-2415
    Google Scholar
  • 31 Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca L, Ferrannini E. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.  Diabetes. 2006;  55 1133-1140
    Google Scholar
  • 32 Cartier A, Lemieux I, Almeras N, Tremblay A, Bergeron J, Despres JP. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.  J Clin Endocrinol Metab. 2008;  93 1931-1938
    Google Scholar
  • 33 Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.  Diabetes Care. 2008;  31 1170-1176
    Google Scholar

Correspondence

Dr. M. Svensson

Department of Nephrology

Sahlgrenska University Hospital

41345 Gothenburg

Sweden

Phone: +46/761/301 133

Fax: +46/31/824 660

Email: maria.svensson@wlab.gu.se

      >